MedAdvisor signs five-year deal with API, bringing hundreds of pharmacies on board
MedAdvisor has signed a five-year agreement with Australian Pharmaceutical Industries (API), which owns the Priceline Pharmacy, Soul Pattinson Chemist and Pharmacist Advice pharmacy banner groups representing approximately 450 pharmacies.
The agreement is expected to add more than 250 new Priceline pharmacies to the MedAdvisor network – an increase of approximately 7%, with a number of Priceline pharmacies already customers.
MedAdvisor said it will develop a branded version of its mobile application for the Priceline Pharmacy network, which will be linked with the Priceline Sister Club to service its eight million members.
“The COVID-19 pandemic has changed consumer behaviour, with consumers now expecting a frictionless and convenient online pharmacy experience,” said Robert Read, Managing Director and CEO of MedAdvisor.
“This is being accelerated by the rapid adoption of electronic prescriptions tokens.”
MedAdvisor’s software provides workflows for COVID-19 vaccinations, including facilitating booking, storing patient records and retrieving vaccination history for the Australian Immunisation Record (AIR), claiming and uploading to the AIR.
Collectively, the MedAdvisor network has administered almost 6,000 COVID-19 vaccines in the last month.
Richard Vincent, CEO & Managing Director of API, said the company is “delighted” to be improving its digital offering to Priceline Pharmacy customers.
“When combined with our industry-leading loyalty program, [we] will deliver a unique experience that now includes accessing COVID-19 vaccinations services.
“Our partnership with MedAdvisor is an important part of the digital roadmap for Priceline Pharmacy that will create a seamless and integrated customer experience.”
API pharmacies and customers are expected to be able to use the MedAdvisor platform from this quarter.